BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2836557)

  • 1. Molecular structure, localization, and possible functions of the myelin-associated enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase.
    Vogel US; Thompson RJ
    J Neurochem; 1988 Jun; 50(6):1667-77. PubMed ID: 2836557
    [No Abstract]   [Full Text] [Related]  

  • 2. 2',3'-cyclic nucleotide 3'-phosphodiesterase, an oligodendrocyte-Schwann cell and myelin-associated enzyme of the nervous system.
    Sprinkle TJ
    Crit Rev Neurobiol; 1989; 4(3):235-301. PubMed ID: 2537684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in the study of cyclic nucleotide phosphodiesterases].
    Zhou HL; Bian RL
    Sheng Li Ke Xue Jin Zhan; 1995 Jul; 26(3):213-7. PubMed ID: 8584886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function.
    Thompson WJ
    Pharmacol Ther; 1991; 51(1):13-33. PubMed ID: 1663250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2',3'-cyclic nucleotide 3'-phosphodiesterase in CNS and PNS myelin: two molecular forms.
    Matthieu JM
    J Neurochem; 1986 Dec; 47(6):1963. PubMed ID: 3021911
    [No Abstract]   [Full Text] [Related]  

  • 6. Developmental expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase mRNA in brains of normal and quaking mice.
    Kurihara T; Takahashi Y; Fujita N; Sato S; Miyatake T
    Brain Res Mol Brain Res; 1989 May; 5(3):247-50. PubMed ID: 2542718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelin: not just a conduit for conduction.
    Popko B
    Nat Genet; 2003 Mar; 33(3):327-8. PubMed ID: 12610543
    [No Abstract]   [Full Text] [Related]  

  • 8. Overexpression of 2',3'-cyclic nucleotide 3'-phosphodiesterase in transgenic mice alters oligodendrocyte development and produces aberrant myelination.
    Gravel M; Peterson J; Yong VW; Kottis V; Trapp B; Braun PE
    Mol Cell Neurosci; 1996 Jun; 7(6):453-66. PubMed ID: 8875429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination.
    Lappe-Siefke C; Goebbels S; Gravel M; Nicksch E; Lee J; Braun PE; Griffiths IR; Nave KA
    Nat Genet; 2003 Mar; 33(3):366-74. PubMed ID: 12590258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the myelin membrane enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase: evidence for two human mRNAs.
    Douglas AJ; Thompson RJ
    Biochem Soc Trans; 1993 May; 21(2):295-7. PubMed ID: 8395421
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular cloning of the myelin specific enzyme 2',3'-cyclic-nucleotide 3'-phosphohydrolase.
    Vogel US; Thompson RJ
    FEBS Lett; 1987 Jun; 218(2):261-5. PubMed ID: 3036592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the association of 2',3'-cyclic-nucleotide 3'-phosphodiesterase with myelin-related membranes in peripheral nervous system.
    Matthieu JM; Costantino-Ceccarini E; Bény M; Reigner J
    J Neurochem; 1980 Dec; 35(6):1345-50. PubMed ID: 6255099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory mechanisms of particulate cyclic nucleotide phosphodiesterases.
    Thompson WJ; Lavis VR; Whalin ME; Strada SJ
    Adv Second Messenger Phosphoprotein Res; 1992; 25():165-84. PubMed ID: 1313258
    [No Abstract]   [Full Text] [Related]  

  • 14. Structural similarities and functional differences clarify evolutionary relationships between tRNA healing enzymes and the myelin enzyme CNPase.
    Muruganandam G; Raasakka A; Myllykoski M; Kursula I; Kursula P
    BMC Biochem; 2017 May; 18(1):7. PubMed ID: 28511668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular messengers. Influence of oligodendrocyte substratum adhesion.
    Vartanian T; Dawson G; Szuchet S
    Ann N Y Acad Sci; 1988; 540():433-6. PubMed ID: 2462818
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of halothane on brain 2',3'-cyclic nucleotide 3'-phosphodiesterase during neurodevelopment in the rat.
    Nagelhout JJ; Ferdinand RT; Beuthin FC
    Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):261-4. PubMed ID: 3020653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2',3'-cyclic nucleotide 3'-phosphodiesterase has characteristics of cytoskeletal proteins. A hypothesis for its function.
    Braun PE; Bambrick LL; Edwards AM; Bernier L
    Ann N Y Acad Sci; 1990; 605():55-65. PubMed ID: 2176445
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes.
    Nicholson CD; Challiss RA; Shahid M
    Trends Pharmacol Sci; 1991 Jan; 12(1):19-27. PubMed ID: 1848733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of the central and peripheral nervous system myelin membrane 2', 3'-cyclic nucleotide 3'-phosphodiesterase in development.
    Edwards AM; Braun PE
    Dev Neurosci; 1988; 10(2):75-80. PubMed ID: 2841085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detergent activation and solubilization of 2':3'-cyclic nucleotide 3'-phosphodiesterase from isolated myelin and c6 cells.
    Sims NR; Horvath LB; Carnegie PR
    Biochem J; 1979 Aug; 181(2):367-75. PubMed ID: 227362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.